GETTING MY ABBV-744 BRD4 INHIBITOR CLINICAL EFFICACY IN REFRACTORY CANCERS TO WORK

These side effects had been notably milder when compared with an inhibitor of both bromodomains. A detailed molecular Examination also disclosed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen TaylorProbable new techniques for the diagnosis and treatment of AML. (A) The identification of